Kostyszyn et al. [24] trained a network on 142 treatment naïve primary PCa patients imaged with [68Ga]Ga-PSMA-11 PET/CT and validated it on an internal ([68Ga]Ga-PSMA-PET and [18F]F-PSMA-1007 PET, in n = 18 and n = 19, respectively) and external patient cohort ([68Ga]Ga-PSMA-11 PET, n = 18). The gene discussed is FOLH1; the disease is posterior cortical atrophy.